mRNA COVID-19 Vaccines Linked to 25% Lower Risk of Death

A groundbreaking new study has found that mRNA COVID-19 vaccines are associated with a significant reduction in mortality risk.

TL;DR
• A new study of 28.7 million people in France found that mRNA COVID-19 vaccines were associated with a 25% lower risk of death from any cause.
• The study controlled for various factors, including age, sex, and pre-existing health conditions.
• The findings suggest that mRNA COVID-19 vaccines are safe and effective.

Summary
A recent study analyzing data from nearly half of France's population found that individuals who received mRNA COVID-19 vaccines had a 74% lower risk of death from COVID-19 and a 25% lower risk of death from any cause over a four-year period. The study, which tracked 28.7 million people, including 22.8 million who received the first dose of an mRNA vaccine, revealed that 0.4% of the vaccinated cohort died compared to 0.6% of the unvaccinated. Key findings include:
• The vaccinated group had a slightly higher average age and more women.
• The vaccinated were more likely to have cardiometabolic conditions (9.3% vs 7.8%).
• The mortality gap was 29% in the first six months after vaccination.

The study's large sample size and extensive data provide strong evidence for the safety and effectiveness of mRNA vaccines. By examining deaths from all causes over 45 months, the research offers a more comprehensive understanding of the vaccines' impact. While the study does not provide definitive proof that the vaccine alone caused the observed effects, it suggests that claims about the vaccine posing a significant risk to life are increasingly implausible.

The findings are particularly relevant given previous concerns and misinformation about mRNA vaccines. A leaked memo from the FDA's Center for Biologics Evaluation and Research had claimed 10 deaths were caused by mRNA vaccines, but this was rejected by 12 former FDA heads and contradicted by consistent evidence from scientific studies.

The study's results have significant implications for public health policy and vaccine development. By demonstrating the safety and efficacy of mRNA vaccines, the research supports their continued use and development as a crucial tool in preventing COVID-19 and reducing mortality. The study's authors note that disentangling the effect of the vaccine alone will be difficult due to residual confounding factors, but the data provides strong evidence for the benefits of vaccination.

The results of this study have significant implications for public health policy and individual decision-making regarding COVID-19 vaccination.